Veritas In Silico Conducts Preparatory Meeting with PMDA for Commercialization of "Perfusio" Drug Delivery System

AI Summary (NQ-processed)

Veritas In Silico Inc. announced it has completed a preparatory meeting with Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its innovative drug delivery system, "Perfusio". The system temporarily isolates an organ from systemic circulation, enabling targeted drug delivery and retrieval to avoid systemic exposure. Following discussions with the PMDA, the company has established a regulatory pathway to seek approval as a general medical device without new data acquisition trials, targeting a market launch in FY2026-2027.